Analysis of Antimicrobial Resistance and Infection Characteristics of Myroides odoratimimus Harboring the blaMOC-1 Metallo-β-Lactamase Gene Authors: Rong Ding, Guiping Xia, Huacheng Tong Published: 2026 ABSTRACT AbstractTo investigate the drug resistance genotype and phenotypic characteristics of a clinical isolate of Myroides odoratimimus producing metallo-β-lactamase, so as to provide reference for the diagnosis and treatment of similar severe infections in critical care settings. A Gram-negative bacillus isolated from blood cultures of an elderly patient with severe bloodstream infection was identified using the Vitek 2 Compact system combined with 16S rRNA gene sequencing. Antimicrobial susceptibility testing was performed using the broth microdilution method to determine minimum inhibitory concentrations (MICs). Metallo-β-lactamase phenotype was identified by the modified carbapenem inactivation method (mCIM) combined with the EDTA-modified carbapenem inactivation method (eCIM). The isolate was identified as Myroides odoratimimus. Both mCIM and eCIM tests were positive, confirming the production of metallo-β-lactamase. Whole-genome sequencing and database comparison revealed the presence of the blaMOC-1 gene in this strain, and PCR amplification followed by sequencing of electrophoretic bands yielded a 629-bp blaMOC-1 sequence. Antimicrobial susceptibility testing showed that the isolate exhibited broad-spectrum resistance and was only susceptible to minocycline, doxycycline, levofloxacin, and cefepime. The patient presented with severe septic shock, showed no response to empirical therapy, developed multiple organ injury, and exhibited abnormally elevated biomarkers of inflammation, metabolism, and cardiovascular function. The findings of this study suggest that the blaMOC-1 gene is carried by this strain and is associated with its broad-spectrum antimicrobial resistance characteristics. Introduction The genus Myroides spp comprises a group of aerobic Gram-negative bacilli belonging to the family Flavobacteriaceae, mainly consisting of Myroides odoratus, Myroides odoratimimus, and the recently identified Myroides injenensis.1–3 Among these, Myroides odoratimimus was previously considered a low-virulence environmental saprophyte and was rarely isolated from clinical specimens. However, in recent years, an increasing number of studies have reported that Myroides odoratimimus infections can lead to significant mortality and complications, with diverse clinical manifestations including septic shock, pneumonia, cellulitis, urinary tract infections, and necrotizing fasciitis. Such infections are more commonly observed in intensive care units (ICUs), where the high proportion of patients with indwelling catheters and immunosuppression provides favorable conditions for the colonization and dissemination of this opportunistic pathogen.4–6 Due to the intrinsic resistance of Myroides spp to multiple antimicrobial agents, the clinically available therapeutic options are extremely limited, often resulting in treatment failure. In recent years, there have been more and more reports of serious infections caused by aromatic bacteria that produce metal β-lactamase (MBL) around the world. In 2017, Su Xu et al 7 identified another novel MBL gene, designated blaMOC-1. This study analyzed the resistance phenotype and clinical infection characteristics of a strain of Myroides odoratimimus carrying the blaMOC-1-type metallo-β-lactamase gene, isolated from a blood culture of a patient with septic shock admitted to the emergency intensive care unit. This strain exhibited unique resistance phenotypes and clinical pathogenic characteristics, and is reported herein to provide reference for the clinical diagnosis and treatment of such infections. Materials and Methods Strain Source The strain used in this study was isolated from a positive blood culture bottle obtained from an elderly patient upon emergency admission, yielding a single pure cultured pathogen. After completion of identification and antimicrobial susceptibility testing, pure colonies were picked using an inoculation loop and stored in strain preservation tubes at −80°C. Culture and Identification Specimen inoculation and isolation were performed in accordance with the National Clinical Laboratory Operating Procedures. Positive blood culture specimens were inoculated onto blood agar plates, chocolate agar plates, and MacConkey agar plates, and incubated at 35°C in a 5% CO2 incubator for 18–24 hours. Typical colonies on blood agar plates were selected for pure culture. Biochemical identification was performed using the Vitek 2 Compact system. Meanwhile, genomic DNA of the strain was extracted, and PCR amplification was performed using universal 16S rRNA gene primers (F: 5′-AGAGTTTGATCCTGGCTCAG-3′; R: 5′-ACGGCTACCTTGTTACGACTT-3′). The amplified products were sequenced and subjected to homology alignment with sequences in the GenBank database for confirmation. Antimicrobial Susceptibility Testing The broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of antimicrobial agents. A total of 18 clinically commonly used antimicrobial agents were tested, including minocycline, doxycycline, cefepime, levofloxacin, ciprofloxacin, imipenem, and meropenem. The operations were strictly performed in accordance with the Clinical and Laboratory Standards Institute (CLSI) 2022 M100 32nd edition standards, with E. coli ATCC 25922 used as the quality control strain. Results were interpreted as susceptible (S), intermediate (I), or resistant (R) based on MIC values. mCIM Combined with eCIM for Metallo-β-Lactamase Detection One microliter of a full loop of the test strain was inoculated into two tubes containing 2 mL of TSB (mCIM and eCIM tubes) and vortexed for 10–15 seconds. To the eCIM tube, 20 μL of 0.5 M EDTA (final concentration 5 mmol/L) was added and mixed. Blank and quality control controls were also set up. A 10-μg meropenem disk was added to each tube, and the tubes were incubated at 35°C ± 2°C in ambient air for 4 h ± 15 min. A 0.5 McFarland turbidity suspension of E. coli ATCC 25922 was prepared and spread onto MHA plates within 15 minutes, then dried for 3–10 minutes. The disks were removed from each tube and placed onto the plates, followed by incubation at 35°C ± 2°C for 18–24 hours. Inhibition zone diameters were measured according to CLSI M100 32nd edition standards. Whole-Genome Sequencing and Resistance Gene Analysis Genomic DNA was extracted using the Omega Bio-Tek Bacterial DNA Kit (Omega Bio-Tek, USA). Sequencing services were provided by Novogene Co., Ltd., using the Illumina NovaSeq 6000 platform (Illumina Inc., USA). A paired-end library with an average insert size of 350 bp (range 150–600 bp) was constructed for sequencing. The raw sequencing reads obtained were assembled and corrected de novo using SPAdes software (v.3.15.4) to generate the genome sequence. The assembled whole-genome sequence was then analyzed for antibiotic resistance genes using the Comprehensive Antibiotic Resistance Database (CARD, https://card.mcmaster.ca/). Metallo-β-Lactamase Gene Detection Nucleic Acid Extraction Total DNA of the strain was extracted by the boiling method: pure colonies were picked and suspended in 50 μL of sterile deionized water, boiled in a water bath for 10 minutes, placed on ice for 5 minutes, and centrifuged at 12,000 r/min for 5 minutes. The supernatant was used as the template. blaMOC-1 Gene Amplification and Sequencing Specific primers were designed based on the blaMOC-1 gene sequence from the National Center for Biotechnology Information (NCBI) (F: 5′-CGTATTCGCTCAATCCAAACCC-3′; R: 5′-GCGTTCTGTATTCTCGATATGACCG-3′), with an amplification product length of 629 bp. PCR reaction conditions were as follows: initial denaturation at 95°C for 5 minutes; 35 cycles of denaturation at 95°C for 30 seconds, annealing at 56°C for 30 seconds, and extension at 72°C for 60 seconds; and final extension at 72°C for 10 minutes. The amplification products were detected by 1.7% agarose gel electrophoresis. Positive fragments were excised and purified, then sequenced by Shanghai Sangon Biotech Co., Ltd. The results were compared using the BLAST tool against the GenBank database. Analysis of Clinical Infection Characteristics The patient’s medical records and laboratory results were reviewed to understand the disease progression and outcome. Results Culture and Identification Results After 24 hours of culture on blood agar plates, strain formed pale yellow, convex, smooth, opaque colonies approximately 2.0 mm in diameter (Figure 1A). Gram staining showed Gram-negative bacilli (Figure 1B). The Vitek 2 Compact system identified the strain as Myroides odoratimimus, and 16S rRNA gene sequencing showed 100% homology with the GenBank reference sequence, confirming it as Myroides odoratimimus. Figure 1(A) Colony morphology on blood agar plate at 24 hours; (B) Gram staining (×1000).Composite image: A) red agar with pale colonies; B) purple-stained rods on light background. (A) Colony morphology on blood agar plate at 24 hours; (B) Gram staining (×1000). Antimicrobial Susceptibility Test Results A total of 18 antimicrobial agents were tested. The results showed 4 susceptible agents (minocycline, doxycycline, levofloxacin, cefepime), 1 intermediate agent (ciprofloxacin), and 13 resistant agents (imipenem, meropenem, etc). Detailed results are presented in Table 1.Table 1Antimicrobial Susceptibility Test Results for StrainAntibioticTest MethodResult (MIC: μg/mL)InterpretationMinocyclineBroth MicrodilutionMIC ≤ 0.5SDoxycyclineBroth MicrodilutionMIC = 2.0SLevofloxacinBroth MicrodilutionMIC = 0.5SCefepimeBroth MicrodilutionMIC = 8.0SCiprofloxacinBroth MicrodilutionMIC = 2.0IImipenemBroth MicrodilutionMIC ≥ 16.0RMeropenemBroth MicrodilutionMIC ≥ 16.0RAmikacinBroth MicrodilutionMIC ≥ 64.0RCeftriaxoneBroth MicrodilutionMIC ≥ 64.0RGentamicinBroth MicrodilutionMIC ≥ 16.0RPiperacillin/TazobactamBroth MicrodilutionMIC ≥ 128.0RTrimethoprim/SulfamethoxazoleBroth MicrodilutionMIC = 160.0RCefoperazone/SulbactamBroth MicrodilutionMIC ≥ 64.0RCefazolinBroth MicrodilutionMIC ≥ 64.0RCeftazidimeBroth MicrodilutionMIC ≥ 64.0RTobramycinBroth MicrodilutionMIC ≥ 16.0RAztreonamBroth MicrodilutionMIC ≥ 64.0RColistinBroth MicrodilutionMIC ≥ 16.0R Table 1Antimicrobial Susceptibility Test Results for StrainAntibioticTest MethodResult (MIC: μg/mL)InterpretationMinocyclineBroth MicrodilutionMIC ≤ 0.5SDoxycyclineBroth MicrodilutionMIC = 2.0SLevofloxacinBroth MicrodilutionMIC = 0.5SCefepimeBroth MicrodilutionMIC = 8.0SCiprofloxacinBroth MicrodilutionMIC = 2.0IImipenemBroth MicrodilutionMIC ≥ 16.0RMeropenemBroth MicrodilutionMIC ≥ 16.0RAmikacinBroth MicrodilutionMIC ≥ 64.0RCeftriaxoneBroth MicrodilutionMIC ≥ 64.0RGentamicinBroth MicrodilutionMIC ≥ 16.0RPiperacillin/TazobactamBroth MicrodilutionMIC ≥ 128.0RTrimethoprim/SulfamethoxazoleBroth MicrodilutionMIC = 160.0RCefoperazone/SulbactamBroth MicrodilutionMIC ≥ 64.0RCefazolinBroth MicrodilutionMIC ≥ 64.0RCeftazidimeBroth MicrodilutionMIC ≥ 64.0RTobramycinBroth MicrodilutionMIC ≥ 16.0RAztreonamBroth MicrodilutionMIC ≥ 64.0RColistinBroth MicrodilutionMIC ≥ 16.0R Antimicrobial Susceptibility Test Results for Strain mCIM Combined with eCIM Results The quality control strain results met expectations, confirming the validity of the test. Interpretation criteria: mCIM inhibition zone of 6–15 mm or 16–18 mm with colonies growing inside was interpreted as carbapenemase-positive; ≥19 mm as negative; 16–18 mm or ≥19 mm with pinpoint colonies as indeterminate. An eCIM and mCIM zone diameter difference of ≥5 mm was interpreted as metallo-β-lactamase-positive, and ≤4 mm as negative. Quality control strain results met expectations, and the blank control inhibition zone was ≥19 mm. Whole-Genome Sequencing Resistance Gene Analysis Results Analysis using the Comprehensive Antibiotic Resistance Database showed that the strain in this study carried the blaMOC-1 metallo-β-lactamase gene (percentage identity of matched region: 99.6%; length coverage of reference sequence: 100.00%). blaMOC-1 Gene Amplification and Sequencing Results PCR amplification products were detected by 1.7% agarose gel electrophoresis, revealing a specific band at approximately 600 bp (Figure 2), consistent with the expected amplified fragment size. Sequencing results were compared using BLAST and showed 99.46% homology with the blaMOC-1 gene of the Myroides odoratus XSfan strain in GenBank (accession No. KX371616.1), and 99.29% homology with the blaMOC-2 gene (accession No. PV587122.1), confirming that this strain carries the blaMOC-1 metallo-β-lactamase gene. The Sanger sequencing product length was 629 bp, with partial sequence shown in Figure 3. Figure 2PCR electrophoresis analysis of the metallo-β-lactamase gene in Myroides odoratimimus.Gel image: lanes M, MOC-1, N; base pair scale 100-3000.Abbreviations: M, marker; N, negative control; MOC-1, metallo-β-lactamase gene. Figure 3Sequencing results of the blaMOC-1 amplification product.Six-trace-row deoxyribonucleic acid sequencing electropherogram with printed base calls. X-axis label and unit are not shown; the horizontal direction represents successive base positions along the read. Y-axis label and unit are not shown; peak height represents relative fluorescence signal intensity. Each row overlays four signal traces for the four nucleotides and a single-letter base call is printed under the peaks using A, C, G and T. Across most rows, peaks are narrow and closely spaced, with many positions showing one dominant peak aligned to the printed base call. Several positions show taller isolated peaks and a few short regions show overlapping peaks of similar height, indicating less distinct base calling at those positions. No numeric tick marks, scales, or legend are present.A deoxyribonucleic acid sequencing electropherogram with base calls A, C, G and T across six reads. PCR electrophoresis analysis of the metallo-β-lactamase gene in Myroides odoratimimus. Sequencing results of the blaMOC-1 amplification product. Clinical Infection Characteristics Analysis The patient was a 74-year-old elderly male admitted to the emergency department with “altered mental status for 4 hours,” requiring endotracheal intubation and mechanical ventilation. The patient had a history of hypertension and type 2 diabetes mellitus, with multiple pustules and blisters over the whole body, accompanied by coma and urinary incontinence. Admission vital signs: body temperature 36.4°C, pulse 50 beats/min, respiration 16 breaths/min, blood pressure 142/112 mmHg. Laboratory tests revealed anemia, thrombocytopenia, hypoproteinemia, and hepatorenal failure. The clinical diagnosis was septic shock and bloodstream infection. The underlying disease was pemphigus, with secondary Gram-negative bacillus septicemia resulting from skin breakdown, manifesting as septic shock and multiple organ dysfunction, with significantly elevated inflammatory markers (CRP, PCT, IL-6, etc)., progressive thrombocytopenia, and coagulation abnormalities (Table 2). Empirical treatment with piperacillin-tazobactam was initiated, later changed to meropenem, but the patient’s condition did not improve significantly. Ultimately, the family opted to discontinue treatment, and the patient was discharged; subsequent follow-up confirmed the patient’s death.Table 2Sepsis-Related IndicatorsDateWBC (×109/L)CRP (mg/L)PCT (ng/mL)IL-6 (pg/mL)Platelets (×109/L)Albumin (g/L)Creatinine (μmol/L)Hemoglobin (g/L)D-dimer (mg/L)Fibrinogen (g/L)NT-proBNP (pg/mL)Day12.5185.16.14>50009024.3123.91042.16.5-Day220.9313.8-44134525.8-92---Day315.9320--3021.6174.984-10.35930 Table 2Sepsis-Related IndicatorsDateWBC (×109/L)CRP (mg/L)PCT (ng/mL)IL-6 (pg/mL)Platelets (×109/L)Albumin (g/L)Creatinine (μmol/L)Hemoglobin (g/L)D-dimer (mg/L)Fibrinogen (g/L)NT-proBNP (pg/mL)Day12.5185.16.14>50009024.3123.91042.16.5-Day220.9313.8-44134525.8-92---Day315.9320--3021.6174.984-10.35930 Sepsis-Related Indicators Discussion Myroides odoratimimus, as an opportunistic pathogen of the family Flavobacteriaceae, is widely distributed in natural environments and hospital settings. Infections are more commonly observed in elderly, immunocompromised patients and those undergoing invasive procedures,7,8 typically causing soft tissue and urinary tract infections. Bacteremia most frequently occurs secondary to soft tissue or catheter-related infections, and in rare cases may lead to death. The patient in this study was an elderly male with underlying comorbidities including hypertension and diabetes mellitus, with impaired skin and mucosal barriers, placing him in a high-risk group for infection. The eventual progression to septic shock suggests that this organism has strong invasiveness and significant clinical harm in immunocompromised hosts. One of the core mechanisms of bacterial resistance to carbapenems is the production of metallo-carbapenemases, which can efficiently hydrolyze various β-lactam antibiotics, including carbapenems.9–12 Previous studies have reported that plasmids containing the blaMOC gene, when transformed into E. coli DH5α by electroporation, resulted in recipient strains with significantly enhanced resistance to β-lactam antibiotics, as confirmed by PCR detection and MIC determination. The blaMOC-positive E. coli DH5α strain showed substantially increased resistance to ampicillin and piperacillin/tazobactam; slightly increased resistance to cefoxitin, ceftazidime, imipenem, and meropenem; but no significant increase in resistance to aztreonam and cefepime.13 The β-lactamase purified from F. odoratum by Sato et al 14 was shown to hydrolyze oxyimino-cephalosporins, cephamycins, imipenem, and penicillins. The metalloenzymes MUS-1, MUS-2, and TUS-1 identified in Myroides strains belong to metalloenzyme subclass 3a and Ambler class B1, capable of hydrolyzing most β-lactam drugs except aztreonam and cefepime. These MBLs share similar hydrolytic functions, enhancing resistance to most β-lactams, particularly penicillins and carbapenems. In this study, the mCIM combined with eCIM method confirmed that the strain produced metallo-β-lactamase, further Whole genome sequencing and PCR amplification and sequencing confirmed the presence of the blaMOC-1 gene. This gene encodes a subclass B1 metallo-β-lactamase, is chromosomally located, and is a metalloenzyme-encoding gene unique to Myroides odoratimimus. More and more studies show that its expression is associated with carbapenem resistance in the strain, which is consistent with the susceptibility results indicating resistance to both imipenem and meropenem. Since this enzyme can efficiently hydrolyze various β-lactam drugs including carbapenems, and serine β-lactamase inhibitors such as avibactam do not inhibit metallo-β-lactamases, the strain exhibited high-level resistance to imipenem, meropenem, and ceftazidime/avibactam, likely related to the fact that the blaMOC-1-encoded metalloenzyme can hydrolyze ceftazidime, and avibactam does not inhibit metalloenzymes.12–15 This finding further highlights the severity of resistance in this strain. However, detection of resistance markers does not always predict antimicrobial treatment failure; genes may be non-functional or expressed at levels of no clinical significance.12 Literature indicates that, depending on antimicrobial susceptibility test results, The empirical treatment regimens commonly used in Nordic countries (second- or third-generation cephalosporins or piperacillin-tazobactam) rarely cure Myroides spp. infections, making antimicrobial susceptibility testing essential. For bacteria lacking established susceptibility breakpoints, interpretation of susceptibility test results presents considerable challenges.16,17 In clinical practice, patients often fail to respond to initial empirical therapy. In the present case, the antimicrobial susceptibility results indicated that the strain was resistant to both the initially selected piperacillin-tazobactam and the subsequently escalated meropenem, which was consistent with the clinical course of empirical anti-infective treatment failure. This further indicates that for such metallo-β-lactamase-producing resistant strains, early acquisition of susceptibility results and selection of sensitive agents such as minocycline may be of critical importance. This also fully demonstrates that precise pathogen detection plays a key guiding role in the treatment of severe infections. Clinicians should note that Myroides spp has strong adhesion capabilities and can be transmitted through indwelling catheters and broken skin. Key departments such as ICUs should strengthen environmental disinfection (particularly water sources and medical equipment surfaces), hand hygiene, and aseptic procedures to reduce the risk of cross-infection.18,19 In addition, this study has some limitations, we only focused on the β-lactamase gene blaMOC-1. Studies have shown that efflux pumps or other resistance mechanisms may also play important roles in the extensive antimicrobial resistance of Pseudomonas putida.20–22 Moreover, we did not perform kinetic determination of blaMOC-1 gene expression levels, and future studies could be designed to investigate the functions of these genes. In this study, Myroides odoratimimus carried the blaMOC-1 gene and exhibited enzymatic activity. Based on the antimicrobial susceptibility results, this gene is associated with the broad-spectrum antimicrobial resistance characteristics of this bacterium. Although the genus Myroides as an opportunistic pathogen has a low clinical infection rate, due to its extensive drug resistance and occasional risk of nosocomial outbreaks, in future severe infections similar to this case, once this organism is cultured, appropriate antimicrobial agents should be administered based on its resistance profile. Future considerations should include how to shorten the time for culture and identification, to enable timely administration of appropriate antimicrobial therapy within the therapeutic window, thereby improving patient outcomes. Additionally, prevention of transmission and nosocomial outbreaks of this organism should be emphasized to avoid causing harm to more patients.